Wednesday, 20 September 2017 - 5:26

Top stories

News of the week

Teva announces new divestiture: Women’s Health sold for $1.38bn

Teva Pharmaceuticals has split its Women’s Health division into two and has sold the two parts for $1,378bn through two deals: one with CVC Capital, another with Foundation Consumer Healthcare. As part of the agreement, CVC Capital will acquire for…

Approvals

Procedures / New drug and device authorizations / Recommendations

Sifi reaches Asia: Mini Well Ready approved in South Corea

Italy-based pharmaceutical group Sifi, focusing on developing and marketing solutions for eye diseases, today announced that the South-Corean authorities have approved the Mini Well Ready intraocular lens. Mini Well Ready is a progressive intraocular lens with extended depth of focus,…

Companies

Healthcare market news

BASF acquires Solvay’s Polyamide unit for €1.6bn

As it was already known, Solvay was searching for a buyer of its Polyamide division and investors were not surprised today as it was announced that the company has sold the asset to Germany-based BASF. BASF paid €1.6bn, corresponding to…

Chemistry

Market and Technology

BASF acquires Solvay’s Polyamide unit for €1.6bn

As it was already known, Solvay was searching for a buyer of its Polyamide division and investors were not surprised today as it was announced that the company has sold the asset to Germany-based BASF. BASF paid €1.6bn, corresponding to…

M&A

Mergers & Acquisitions

BASF acquires Solvay’s Polyamide unit for €1.6bn

As it was already known, Solvay was searching for a buyer of its Polyamide division and investors were not surprised today as it was announced that the company has sold the asset to Germany-based BASF. BASF paid €1.6bn, corresponding to…

Nutraceuticals

Food supplements

Multiple sclerosis and vitamin D: new data supporting the link

The review Neurology has published the results from an extensive study confirming that Vitamin D deficiency can be a risk factor for the onset of multiple sclerosis. The researchers analyzed a sample of healthy individuals, measuring their vitamin D levels…

Pathology

Latest developments

Research on new cancer therapies: state of the art

The Economist has chosen the state of the art of cancer therapies as the latest Technology Quarterly’s topic. Cancer kills 8.8m people each year and affects at least one on three people in western countries. Although this death rate is…

Safety

News on Product Safety

The skin lightening market

The business of skin-lightening treatments is growing at an impressive rate and is expected to increase from the current $10bn to $31bn before 2024. This dramatic increase is due to an association between fair skin and beauty and success –…

Trials

Preclinical Trials / Clinical Trials / Epidemiology

Multiple sclerosis and vitamin D: new data supporting the link

The review Neurology has published the results from an extensive study confirming that Vitamin D deficiency can be a risk factor for the onset of multiple sclerosis. The researchers analyzed a sample of healthy individuals, measuring their vitamin D levels…